Valturna Side Effects

Although most people tolerate Valturna well, others may develop problems while taking this medication. The most common side effects of Valturna include high blood potassium levels, fatigue, and symptoms of the common cold. Reactions to this drug tend to be minor and easy to treat. However, if you develop any potentially serious problems, such as seizures or swelling of the mouth, seek immediate medical attention.

An Introduction to Valturna Side Effects

As with any medicine, side effects are possible with Valturna® (aliskiren and valsartan). However, not everyone who takes the medication will have problems. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or are easily treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with Valturna. Your healthcare provider can discuss a more complete list with you.)
 

Common Side Effects of Valturna

Valturna has been studied thoroughly in clinical trials.
 In these studies, the side effects that occur in a group of people taking the drug are documented and are then compared to those that occur in another group of people taking a placebo (a "sugar pill" with no active ingredients). This way, it is possible to see what side effects occur, how often they appear, and how they compare to the placebo.
 
In these studies, the most common Valturna side effects included:
 
  • High blood potassium levels (hyperkalemia) -- in up to 4 percent of people
  • Fatigue -- up to 2.6 percent
  • Common cold symptoms (such as sore throat or runny nose) -- up to 2.6 percent
  • Diarrhea -- up to 1.4 percent
  • Upper respiratory tract infection -- up to 1.4 percent
  • Urinary tract infection (UTI), such as a bladder infection -- up to 1.4 percent
  • The flu -- up to 1.1 percent
  • A spinning sensation -- up to 1.1 percent.
     
Valturna Side Effects Article Continues on Next Page >
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation